These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease. Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825 [TBL] [Abstract][Full Text] [Related]
44. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker. Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342 [TBL] [Abstract][Full Text] [Related]
45. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis. Cong S; Xiang C; Wang H; Cong S J Neurol; 2021 Aug; 268(8):2703-2712. PubMed ID: 32162061 [TBL] [Abstract][Full Text] [Related]
47. Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes. Reyes JF; Sackmann C; Hoffmann A; Svenningsson P; Winkler J; Ingelsson M; Hallbeck M Acta Neuropathol; 2019 Jul; 138(1):23-47. PubMed ID: 30976973 [TBL] [Abstract][Full Text] [Related]
48. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease. Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996 [TBL] [Abstract][Full Text] [Related]
49. Phosphorylated α-Synuclein Deposits in Cutaneous Nerves of Early Parkinsonism. Nolano M; Caporaso G; Manganelli F; Stancanelli A; Borreca I; Mozzillo S; Tozza S; Dubbioso R; Iodice R; Vitale F; Koay S; Vichayanrat E; da Silva FV; Santoro L; Iodice V; Provitera V J Parkinsons Dis; 2022; 12(8):2453-2468. PubMed ID: 36373295 [TBL] [Abstract][Full Text] [Related]
50. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074 [TBL] [Abstract][Full Text] [Related]
51. The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy. Abdul-Rahman T; Herrera-Calderón RE; Ahluwalia A; Wireko AA; Ferreira T; Tan JK; Wolfson M; Ghosh S; Horbas V; Garg V; Perveen A; Papadakis M; Ashraf GM; Alexiou A CNS Neurosci Ther; 2024 Apr; 30(4):e14678. PubMed ID: 38572788 [TBL] [Abstract][Full Text] [Related]
52. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Stemberger S; Poewe W; Wenning GK; Stefanova N Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840 [TBL] [Abstract][Full Text] [Related]
53. Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography. Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T Front Neurol; 2020; 11():1043. PubMed ID: 33041984 [No Abstract] [Full Text] [Related]
54. Serum miR-30c-5p is a potential biomarker for multiple system atrophy. Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945 [TBL] [Abstract][Full Text] [Related]
55. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos. Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938 [TBL] [Abstract][Full Text] [Related]
56. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology. Ishiguro Y; Tsunemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614 [TBL] [Abstract][Full Text] [Related]
57. Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease. Kluge A; Schaeffer E; Bunk J; Sommerauer M; Röttgen S; Schulte C; Roeben B; von Thaler AK; Welzel J; Lucius R; Heinzel S; Xiang W; Eschweiler GW; Maetzler W; Suenkel U; Berg D Mov Disord; 2024 Aug; 39(8):1289-1299. PubMed ID: 38651526 [TBL] [Abstract][Full Text] [Related]
58. Different patterns of exosomal α-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder. Yan YQ; Pu JL; Zheng R; Fang Y; Gu LY; Guo T; Si XL; Zhou C; Chen Y; Liu Y; Guan XJ; Xu XJ; Yan YP; Yin XZ; Zhang MM; Tao ZH; Zhang BR Eur J Neurol; 2022 Dec; 29(12):3590-3599. PubMed ID: 36047985 [TBL] [Abstract][Full Text] [Related]
59. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Doppler K; Weis J; Karl K; Ebert S; Ebentheuer J; Trenkwalder C; Klebe S; Volkmann J; Sommer C Mov Disord; 2015 Oct; 30(12):1688-92. PubMed ID: 26175301 [TBL] [Abstract][Full Text] [Related]